Clinical Trials at Rady Children's Hospital
As of June 2026, 39 paid clinical trials are recruiting at Rady Children's Hospital, located at 3020 CHILDRENS WAY, 5081, SAN DIEGO, CA 92123-4223, phone (858) 966-1700 in San Diego, California. Active studies at this site cover conditions such as Heart Failure, Obesity and Depression. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
39 clinical trials at Rady Children's Hospital
·Clear filters·↓ Download CSVA Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Dance Mental Health App
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
TReatment for ImmUne Mediated PathopHysiology
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Beat Childhood Cancer Specimen Banking and Data Registry
The Tether™ - Vertebral Body Tethering System Post Approval Study
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Neuroblastoma Maintenance Therapy Trial
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
About research studies in San Diego
San Diego has approximately 813 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Common conditions studied in San Diego
- Heart Failure (15 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Obesity (13 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Depression (12 active studies). Depression studies test rapid-acting antidepressants including ketamine derivatives, psilocybin-assisted therapy, and neuromodulation approaches.
- Major Depressive Disorder (11 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
- Schizophrenia (10 active studies). Schizophrenia research tests muscarinic agonists, long-acting injectable antipsychotics, and cognitive remediation therapies.
- Breast Cancer (9 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in San Diego
- University of California, San Diego
- San Diego State University
- VA Office of Research and Development
- National Cancer Institute (NCI)
- AstraZeneca
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in San Diego. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in San Diego
Hipa.ai aggregates every recruiting study in San Diego from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in San Diego?
There are approximately 813 recruiting clinical trials in San Diego, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in San Diego pay participants?
Most recruiting trials in San Diego compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in San Diego?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in San Diego?
The most common conditions under active study in San Diego include Heart Failure (15), Obesity (13), Depression (12), Major Depressive Disorder (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in San Diego?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in San Diego on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in San Diego?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in San Diego?
Recruiting research sites in San Diego include University of California San Diego, University of California, San Diego, Rady Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in San Diego right now?
The largest active categories in San Diego are Cancer & tumors (166), Mental health & behavior (51), Neurology & pain (51). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Rady Children's Hospital?
Rady Children's Hospital is located at 3020 CHILDRENS WAY, 5081, SAN DIEGO, CA 92123-4223. Use the Google Maps link in the intro above to get directions.
How do I contact Rady Children's Hospital?
You can reach Rady Children's Hospital by phone at (858) 966-1700. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.